Menta Capital’s Innoviva INVA Stock Holding History

Menta Capital’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-28,172	Closed	-$301K	–	892
2016 Q4	$301K	Buy	+28,172	New	+$296K	0.03%	743

Other funds holding INVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Menta Capital's INVA Position: Q1 2017 in Review

Menta Capital sold out of Innoviva (INVA) in Q1 2017, closing a stake of 28,172 shares — an estimated $301K sold.

Menta Capital first reported a position in INVA in Q4 2016 and held it in 1 quarter. The position peaked at $301K in Q4 2016. 164 funds tracked by Wall St. Rank hold INVA as of Q1 2017.

Menta Capital reported no remaining Innoviva position as of Q1 2017 after selling out during the quarter.
Menta Capital sold 28,172 Innoviva shares in Q1 2017, an estimated $301K.
Menta Capital first reported a position in Innoviva in Q4 2016 and held it in 1 quarter.
Menta Capital's Innoviva position peaked at $301K in Q4 2016.
164 funds tracked by Wall St. Rank held Innoviva as of Q1 2017.

Based on Menta Capital's 13F filing for Q1 2017, filed 12 May 2017.